Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Ondansetron × 1 year × Clear all

Sponsor

Conditions

Vomiting 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Postoperative Nausea and Vomiting 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Gynecologic Cancer 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma in Situ 1 Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

Dexamethasone 16 Lenalidomide 12 Bortezomib 9 Cyclophosphamide 7 carfilzomib 6 Whole-Body Irradiation 6 Melphalan 6 fludarabine 5 daratumumab 5 Tacrolimus 5 Mycophenolic Acid 5 Calcium Dobesilate 5 pomalidomide 3 fludarabine phosphate 3 belantamab mafodotin 3 Radiotherapy 3 gamma-Globulins 2 elotuzumab 2 Trimethoprim, Sulfamethoxazole Drug Combination 2 Sirolimus 2 Prednisone 2 Immunoglobulins, Intravenous 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 venetoclax 1 thymoglobulin 1 siltuximab 1 poly ICLC 1 pembrolizumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡